[12] It is used in pediatric patients with intrinsic cobalamin metabolic diseases, vitamin B 12 -deficient patients with tobacco amblyopia due to cyanide poisoning, and patients with pernicious anemia who have optic neuropathy
Knowing both the benefits and risks helps set realistic expectations and allows for a more informed decision
In contrast, Zepbound was originally approved under the name Mounjaro for type 2 diabetes in 2022, followed by Zepbound in 2023 for weight loss
Tirzepatide, on the other hand, is a dual GIP/GLP-1 receptor agonist
Motivations for weight loss extend beyond appearance, as improving fitness and stamina, increasing longevity, and disease prevention were cited as leading reasons by respondents
Breaking long-term habits may feel almost impossible, and all it takes is the smallest lapse in your self-control to put your weight back on